DISTRESS AND PTSD IN PATIENTS WITH CANCER: COHORT STUDY CASE.
DISTRESS AND PTSD IN PATIENTS WITH CANCER: COHORT STUDY CASE.
复制标题
癌症患者的痛苦和创伤后应激障碍：队列研究案例。
DOI：
10.5455/msm.2016.28.12-16
复制
发表时间：
2016-02
期刊：
影响因子：
--
通讯作者：
Ramic E
中科院分区：
文献类型：
--
作者：
Pranjic N;Bajraktarevic A;Ramic E
尴尬的情绪体验可能会影响肿瘤患者有效科普癌症、症状和治疗的能力。痛苦会持续很长一段时间，从普通的、正常的脆弱感、悲伤和恐惧到创伤后应激障碍、抑郁、焦虑、恐慌、社会孤立和对精神危机的感知。这项研究的目的是确定癌症患者的痛苦和创伤后应激障碍的水平。在一项前瞻性队列研究中，2011- 2014年的病例包括在其选择的家庭医学医生的监督下接受治疗的癌症患者。包括患者参与研究的一个因素是，从诊断恶性疾病的那一刻起，时间<12个月。总样本为计划的200个样本中的174个（响应率=87%）。受试者被分为三组。创建该组的一个关键因素是从确认和确认诊断的那一刻起所经过的时间：T1 <14天，n=56例患者; T2>14天-<6个月，n=79例患者; T3>6个月，n=39例患者。为了达到研究的既定目标，使用了3种问卷调查工具：恶性肿瘤患者的临床特征、人口学和个体特征问卷;肿瘤患者苦恼问卷-医院抑郁和焦虑量表、HADS量表（医院焦虑和抑郁量表- HADS）和创伤后应激障碍症状自评快速测试。患者年龄为54.63 ± 11.46岁，被诊断为癌症时的年龄为54.34 ± 11.26岁。痛苦的患病率高达76%（比预期高82倍），PTSD为55%。癌症患者倦怠综合征的预测因子都是恶性疾病的重要决定因素：自疾病诊断以来所经过的时间决定了恶性疾病的临床状态（β=0.280; P=0.001; 95% CI，0742-2259），发现转移（β=0.304; P=0.001; 95% CI -2621至0978）和治疗（β=0.160; P=0.031，95% CI 0050至1.060）。癌症患者的痛苦问题很普遍，在我们的环境中有76%的高患病率，但仍然缺乏干预和治疗。
embarrassed emotional experience may affect the ability to oncology patient effectively cope with cancer, symptoms and treatment. Distress extends a long period, from common, normal feelings of vulnerability, sadness and fears to problems of PTSD, depression, anxiety, panic, social isolation and the perception of spiritual crisis. The aim of the research is to determine the level of distress and PTSD in cancer patients. In a prospective, cohort study cases from 2011- 2014 were included patients with cancer who are treated under the supervision of his chosen family medicine doctor. Including a factor for the participation of patients in the study is that from the moment of diagnosis of malignant disease passed <12 months. The total sample was 174 of the planned 200 (response rate=87%). The subjects were divided into three groups. A key factor in the creation of the group was the time elapsed from the moment of acknowledgment and confirmation of the diagnosis: T1 <14 days, n=56 patients; T2>14 days-<6 months, n=79 patients; T3>6 months n=39 patients. To achieve the set goals of the research was used instruments of 3 questionnaires: Questionnaire on the clinical characteristics of patients with malignant disease, demographic and individual characteristics; questionnaire distress oncology patient–hospital scales of depression and anxiety, HADS scale (Hospital Anxiety and Depression Scale - HADS) and a rapid test for self-assessment of the symptoms of PTSD. Age of patients was 54.63 ± 11:46 years, and the age of the respondents when they were diagnosed with cancer 54.34 ± 11.26 years. The prevalence of distress was a high 76% 82x higher than expected), and PTSD 55%. Predictors of burnout syndrome in cancer patients are all important determinants of malignant disease: the time elapsed since the diagnosis of the disease which determines the clinical status of malignant disease (β=0.280; P=0.001; 95% CI, 0742-2259), discovered metastases (β=0.304; P=0.001; 95% CI -2621 to 0978) and treatments (β=0.160; P=0.031, 95% CI 0050 to 1.060). The problem of distress in cancer patients is widespread and has a high prevalence of 76% in our environment, while still absent intervention and treatment.